TIMOTHY STEVENS: Open Payments
NPI 1417201419 · MT PLEASANT, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 23 payments from 12 companies in 2025. Trend: 2023 $545 · 2024 $543 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $96 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| PFIZER INC. | 3 | $45 |
| Abbott Laboratories | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 1 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
Products named: VRAYLAR, AIRSUPRA, Auvelity, NURTEC ODT, FREESTYLE LIBRE 3, Qelbree, QULIPTA, ZENPEP.
Industry payments across UT — which companies pay providers there.
